The Rheumatologist
COVID-19 News
  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed
  • Home
  • Conditions
    • Rheumatoid Arthritis
    • SLE (Lupus)
    • Crystal Arthritis
      • Gout Resource Center
    • Spondyloarthritis
    • Osteoarthritis
    • Soft Tissue Pain
    • Scleroderma
    • Vasculitis
    • Systemic Inflammatory Syndromes
    • Guidelines
  • Resource Centers
    • Ankylosing Spondylitis Resource Center
    • Gout Resource Center
    • Psoriatic Arthritis Resource Center
    • Rheumatoid Arthritis Resource Center
    • Systemic Lupus Erythematosus Resource Center
  • Drug Updates
    • Biologics & Biosimilars
    • DMARDs & Immunosuppressives
    • Topical Drugs
    • Analgesics
    • Safety
    • Pharma Co. News
  • Professional Topics
    • Ethics
    • Legal
    • Legislation & Advocacy
    • Career Development
      • Certification
      • Education & Training
    • Awards
    • Profiles
    • President’s Perspective
    • Rheuminations
    • Interprofessional Perspective
  • Practice Management
    • Billing/Coding
    • Quality Assurance/Improvement
    • Workforce
    • Facility
    • Patient Perspective
    • Electronic Health Records
    • Apps
    • Information Technology
    • From the College
    • Multimedia
      • Audio
      • Video
  • Resources
    • Issue Archives
    • ACR Convergence
      • Systemic Lupus Erythematosus Resource Center
      • Rheumatoid Arthritis Resource Center
      • Gout Resource Center
      • Abstracts
      • Meeting Reports
      • ACR Convergence Home
    • American College of Rheumatology
    • ACR ExamRheum
    • Research Reviews
    • ACR Journals
      • Arthritis & Rheumatology
      • Arthritis Care & Research
      • ACR Open Rheumatology
    • Rheumatology Image Library
    • Treatment Guidelines
    • Rheumatology Research Foundation
    • Events
  • About Us
    • Mission/Vision
    • Meet the Authors
    • Meet the Editors
    • Contribute to The Rheumatologist
    • Subscription
    • Contact
  • Advertise
  • Search
You are here: Home / Articles / Rheumatologists on the Move, January 2016

Rheumatologists on the Move, January 2016

January 19, 2016 • By Ann-Marie Lindstrom

  • Tweet
  • Email
Print-Friendly Version / Save PDF

2015 Mary Betty Stevens Young Investigator Prize Awarded to Dr. Timothy Niewold

Timothy B. Niewold, MDTimothy B. Niewold, MD, Mayo Clinic rheumatologist and associate professor of medicine at the Mayo Clinic College of Medicine, Rochester, Minn., was awarded the 2015 Mary Betty Stevens Young Investigator Prize at a reception held during the 2015 ACR/ARHP Annual Meeting in San Francisco. The Lupus Foundation of America presents the Mary Betty Stevens Young Investigator Prize “to recognize exceptional achievements by an investigator in the early part of his or her lupus research career,” according to the award announcement.

You Might Also Like
  • Rheumatologists on the Move, May 2016
  • Rheumatologists on the Move, July 2016
  • Rheumatologists on the Move
Explore This Issue
January 2016
Also By This Author
  • Rheumatologists on the Move, July 2015

The award announcement goes on to say, “Dr. Niewold’s research focuses on the role of genetics and immune-system-signaling molecules in the development and progression of lupus and his insights are important to the development of individualized therapies for people with lupus.”

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

Dr. Niewold says, “We want to understand how genetic factors play out in the biology of a person. What actually happens. What is the chain of events that leads to lupus.”

His laboratory is mapping the genetic factors that cause autoimmune diseases and exploring the ways in which genetic variations alter the human immune response to result in disease. Dr. Niewold has a large body of work that demonstrates ways the normal immune response to viruses is pathologically and persistently activated to result in autoimmune disease, like lupus. For example, interferon normally provides a defense against viruses, but it is frequently activated abnormally in autoimmune disease.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

“We want to understand how interferon changes the immune system. Interferon is turned on all the time in half of lupus patients,” he says. Also, that abnormality seems to be an inherited tendency, because Dr. Niewold says, “There are higher interferon levels in the unaffected family members of lupus patients.”

In addition, his research indicates a heterogeneity in the molecular pathogenesis of autoimmune diseases. Patients with the same condition frequently have different activated molecular pathways. Understanding those differences should provide the information necessary to develop individualized treatments.

“One reason why drugs are difficult to develop for lupus is that the pathways activated in different patients are not the same,” says Dr. Niewold.

ad goes here:advert-3
ADVERTISEMENT
SCROLL TO CONTINUE

Aside from studying the different molecular pathways in patients with the condition, researching patients from different ancestral backgrounds is also important to determine both shared and population-specific pathogenic factors.

He says, “This heterogeneity between patients and the population-specific differences could be a factor in lots of lupus drug trial failures. We need different strokes for different folks.”

2015 Evelyn V. Hess Award Goes to Dr. Mariana Kaplan

Mariana Kaplan, MDMariana Kaplan, MD, chief of the Systemic Autoimmunity Branch in the Intramural Research Program at the National Institute of Arthritis and Musculoskeletal and Skin Diseases at the National Institutes of Health, Bethesda, Md., received the 2015 Evelyn V. Hess Award in November. The Lupus Foundation of American gives the award to an outstanding investigator who significantly advances the understanding of lupus causes and management. Dr. Kaplan received her award at a reception that coincided with the 2015 ACR/ARHP Annual Meeting in San Francisco.

Pages: 1 2 3 4 | Single Page

Filed Under: Career Development, Professional Topics, Profiles Tagged With: Career development, Profiles, rheumatologistIssue: January 2016

You Might Also Like:
  • Rheumatologists on the Move, May 2016
  • Rheumatologists on the Move, July 2016
  • Rheumatologists on the Move
  • Rheumatologists on the Move, October 2016

Rheumatology Research Foundation

The Foundation is the largest private funding source for rheumatology research and training in the U.S.

Learn more »

Simple Tasks

Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.

Visit the Simple Tasks site »

ACR Convergence

Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.

Visit the ACR Convergence site »

The Rheumatologist newsmagazine reports on issues and trends in the management and treatment of rheumatic diseases. The Rheumatologist reaches 11,500 rheumatologists, internists, orthopedic surgeons, nurse practitioners, physician assistants, nurses, and other healthcare professionals who practice, research, or teach in the field of rheumatology.

About Us / Contact Us / Advertise / Privacy Policy / Terms of Use

  • Connect with us:
  • Facebook
  • Twitter
  • LinkedIn
  • YouTube
  • Feed

Copyright © 2006–2021 American College of Rheumatology. All rights reserved.

ISSN 1931-3268 (print)
ISSN 1931-3209 (online)

loading Cancel
Post was not sent - check your email addresses!
Email check failed, please try again
Sorry, your blog cannot share posts by email.
This site uses cookies: Find out more.